Jambulingam, P., Kuttiatt, V. S., Krishnamoorthy, K., Subramanian, S., Srividya, A., Raju, H. K. K., . . . Weil, G. J. (2021). An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India. PLoS Negl Trop Dis.
Styl ChicagoJambulingam, Purushothaman, et al. "An Open Label, Block Randomized, Community Study of the Safety and Efficacy of Co-administered Ivermectin, Diethylcarbamazine Plus Albendazole Vs. Diethylcarbamazine Plus Albendazole for Lymphatic Filariasis in India." PLoS Negl Trop Dis 2021.
Citace podle MLAJambulingam, Purushothaman, et al. "An Open Label, Block Randomized, Community Study of the Safety and Efficacy of Co-administered Ivermectin, Diethylcarbamazine Plus Albendazole Vs. Diethylcarbamazine Plus Albendazole for Lymphatic Filariasis in India." PLoS Negl Trop Dis 2021.